Resultados da busca - Jonathan Wessen
- Mostrando 1 - 2 resultados de 2
-
1
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma por Michael S. Hofman, Ben Tran, Darren R. Feldman, Anna Pokorska-Bocci, Solen Pichereau, Jonathan Wessen, Mohammad B. Haskali, Richard Sparks, Olena Vlasyuk, Ivana Galetić
Publicado em 2024Artigo -
2
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial por Éric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao–Sirieix, Steven W. Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B. Runnebaum, Isabelle Ray‐Coquard
Publicado em 2023Artigo
Ferramentas de busca:
Assuntos relacionados
Biology
Medicine
BRCA mutation
Bevacizumab
Biochemistry
Cancer
Cancer research
Carbonic anhydrase
Chemistry
Chemotherapy
Confidence interval
Enzyme
Gene
Genetics
Germline mutation
Hazard ratio
Homologous recombination
Internal medicine
Molecular biology
Mutation
Nuclear medicine
Olaparib
Oncology
Ovarian cancer
PALB2
PARP inhibitor
Pathology
Pharmacokinetics
Pharmacology
Poly ADP ribose polymerase